Form 4 for TENX TENAX THERAPEUTICS, INC.

Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001841785-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2025-12-10	2025-12-09	TENX	Rich Stuart	Chief Medical Off, Dir	P - Purchase	$10.22	+2,500	5,266	+90%	+$25.6K
I	2025-12-10	2025-12-08	TENX	Rich Stuart	Chief Medical Off, Dir	P - Purchase	$10.10	+2,500	5,000	+100%	+$25.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-12-09	P	A	2,500	$10.22	5,266	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $9.70 to $10.45. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
2	Common	Common Stock	2025-12-08	P	A	2,500	$10.10	5,000	I By Stuart Rich Revocable Trust DTD 11/18/1996	—	—	(F1) This transaction was executed in multiple trades at prices ranging from $9.76 to $10.42. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. (F2) The Reporting Person is trustee of the Stuart Rich Revocable Trust DTD 11/18/1996 and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.